Our Services
Medical Information
Helpful Resources
Published on: 9/14/2026
Lowering an elevated immature granulocyte (IG) count depends entirely on treating the underlying cause, since IGs rise when your bone marrow releases young white blood cells early, most often in response to infection, inflammation, tissue injury, pregnancy, recent surgery, steroid or growth factor medications, or, less commonly, a bone marrow disorder. Treating the trigger, such as clearing a bacterial infection with antibiotics, controlling chronic inflammation, allowing recovery after surgery or trauma, or adjusting medications with your clinician, typically returns the count to normal on its own. Supportive steps like completing prescribed treatment, staying hydrated, sleeping well, eating a nutrient-dense diet, avoiding smoking, and returning for repeat bloodwork help confirm the level is trending down. Persistently high IG counts, especially with fever, fatigue, unexplained weight loss, bruising, or abnormal neutrophil and blast results, need prompt medical evaluation. There are several important factors and warning signs to consider, so see below to understand more.
If you are unsure whether your result reflects a passing infection or something that needs faster attention, a few minutes of clarity can help. Take a free, instant, online symptom check to review your symptoms, understand which causes fit your situation, and learn which type of clinician and tests to ask about next.
Last reviewed for medical accuracy: 09/14/2026
An elevated count of immature granulocytes—as seen on a complete blood count (CBC)—can signal that your body is fighting an infection, inflammation or other underlying issues. “Immature granulocytes” include metamyelocytes, myelocytes and promyelocytes, which normally mature in the bone marrow before entering the bloodstream. When their levels rise, it often means your bone marrow is working overtime. Here’s how to address and potentially lower an elevated immature granulocytes count, based on guidance from trusted medical sources.
The first step is to understand why your immature granulocytes are elevated. Common triggers include:
Work closely with your healthcare provider to pinpoint the cause. This often involves repeat blood tests, imaging or bone marrow evaluation.
Once you know the root cause, follow your doctor’s treatment plan precisely:
Always discuss side effects and follow-up plans. Regular monitoring helps ensure that treatment effectively lowers the immature granulocytes count without undue risk.
Your bone marrow needs the right nutrients to produce healthy, mature blood cells:
Consider a balanced multivitamin if dietary intake may be insufficient—but talk to your doctor before starting any supplement.
Chronic stress and poor sleep can weaken your immune system and indirectly affect blood cell production:
Lower stress levels help your body focus on healing and regulating normal blood cell maturation.
Proper hydration and moderate exercise support healthy circulation and immune function:
Combining hydration with regular, balanced exercise helps maintain optimal blood flow and supports marrow function.
Exposure to certain chemicals or toxins can disrupt bone marrow:
If you suspect work-related or environmental exposure, discuss protective measures or relocation with occupational health experts.
Frequent follow-up is essential:
If you experience significant changes, seek medical attention promptly.
An elevated immature granulocytes count itself isn’t usually an emergency—but watch for red-flag symptoms:
If you experience any of the above, don’t wait. Seek emergency care or call your doctor right away.
If you’re unsure whether your current symptoms require urgent attention, you can do a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance. This tool can help you decide if you need to see a healthcare provider sooner.
Frequent, honest conversations with your doctor ensure you’re on the right path toward normalizing your immature granulocytes count.
By addressing root causes, optimizing your lifestyle and staying in close contact with your healthcare team, you can work toward lowering your immature granulocytes count and restoring balance to your immune system.
(References)
* Akershoek JJ, Brouwer KM, Vlig M, Boekema BKHL, Beelen RHJ, Middelkoop E, Ulrich MMW. Differential effects of Losartan and Atorvastatin in partial and full thickness burn wounds. PLoS One. 2017;12(6):e0179350. doi: 10.1371/journal.pone.0179350. Epub 2017 Jun 14. PMID: 28614412; PMCID: PMC5470692.
* Kanti V, Röwert-Huber J, Vogt A, Blume-Peytavi U. Cicatricial alopecia. J Dtsch Dermatol Ges. 2018 Apr;16(4):435-461. doi: 10.1111/ddg.13498. PMID: 29645394.
* Hashimoto S, Rijssenbeek-Nouwens LH, Fieten KB, Weersink EJ, Bel EH. Predictors of benefit from high-altitude climate therapy in adults with severe asthma. Neth J Med. 2018 Jul;76(5):218-225. PMID: 30019677.
* Kuang FL, Legrand F, Makiya M, Ware J, Wetzler L, Brown T, Magee T, Piligian B, Yoon P, Ellis JH, Sun X, Panch SR, Powers A, Alao H, Kumar S, Quezado M, Yan L, Lee N, Kolbeck R, Newbold P, Goldman M, Fay MP, Khoury P, Maric I, Klion AD. Benralizumab for PDGFRA-Negative Hypereosinophilic Syndrome. N Engl J Med. 2019 Apr 4;380(14):1336-1346. doi: 10.1056/NEJMoa1812185. PMID: 30943337; PMCID: PMC6557265.
* Wang J, Mei T, Liu Y, Zhang Y, Zhang Z, Hu Y, Wang Y, Wu M, Yang C, Zhong X, Chen B, Cui Z, Le W, Liu Z. Dual-targeted and MRI-guided photothermal therapy via iron-based nanoparticles-incorporated neutrophils. Biomater Sci. 2021 Jun 4;9(11):3968-3978. doi: 10.1039/d1bm00127b. PMID: 33666216.
* Alay GH, Tatlisuluoglu D, Bulut K, Fikri BI, Oztas A, Turan G. The relationship between immature granulocyte count and mortality in ARDS Due to COVID-19. Niger J Clin Pract. 2022 Aug;25(8):1301-1307. doi: 10.4103/njcp.njcp_118_22. PMID: 35975379.
* Li TX, Yang YY, Zong JB, Li M, Fu XX, Jiang XX, Wang WT, Li XQ, Qi HZ, Yu T. Activated neutrophil membrane-coated tRF-Gly-CCC nanoparticles for the treatment of aortic dissection/aneurysm. J Control Release. 2025 Feb 10;378:334-349. doi: 10.1016/j.jconrel.2024.12.015. Epub 2024 Dec 19. PMID: 39672274.
* Bal C, Stoshikj S, Renner A, Milger K, Skowasch D, Schulz C, Jandl M, Schmidt O, Ehmann R, Zehetmayer S, Taube C, Hamelmann E, Buhl R, Korn S, Idzko M. German Asthma Net: Characterisation of responders to anti-IL-5 and anti-IL-5(R) therapy. Pulmonology. 2025 Dec 31;31(1):2460868. doi: 10.1080/25310429.2025.2460868. Epub 2025 Feb 13. PMID: 39945136.
* Zborowsky S, Seurat J, Balacheff Q, Ecomard S, Mulet C, Minh CNN, Titécat M, Evrard E, Rodriguez-Gonzalez RA, Marchi J, Weitz JS, Debarbieux L. Macrophage-induced reduction of bacteriophage density limits the efficacy of in vivo pulmonary phage therapy. Nat Commun. 2025 Jul 1;16(1):5725. doi: 10.1038/s41467-025-61268-1. Epub 2025 Jul 1. PMID: 40595615; PMCID: PMC12219145.
* Akkuş FA, Çölkesen F, Önalan T, Gerek ME, Kılınç M, Arslan Ş. Clinical outcomes after switching from omalizumab to anti-IL-5/IL-5R biologics in severe asthma: a retrospective cohort study. BMC Pulm Med. 2025 Nov 26;26(1):4. doi: 10.1186/s12890-025-04044-7. Epub 2025 Nov 26. PMID: 41299451; PMCID: PMC12763992.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.